Marfan syndrome in the third Millennium

被引:61
作者
Collod-Béroud, G
Boileau, C
机构
[1] Hop Necker Enfants Malad, INSERM, U383, Clin Maurice LAMY, F-75743 Paris 15, France
[2] Hop Ambroise Pare, Lab Biochim Hormonol & Genet Mol, F-92104 Boulogne, France
关键词
Marfan syndrome; MFS; FBN1; fibrillin-1; review; structure;
D O I
10.1038/sj.ejhg.5200876
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Marfan syndrome (MFS) is a prominent member of heritable disorders of connective tissue with manifestations involving primarily the skeletal, ocular and cardiovascular systems but also and less systematically investigated the lung, skin and integument, and dura. Over the last two decades, a considerable amount of clinical, molecular and protein data had accumulated. In combination with the study of natural and transgenic animal models, this new information provides greater insight into the pathogenic mechanisms underlying not only the pleiotropic manifestations of MFS but also the important degree of clinical variability (age of onset and severity) observed between patients. The following aspects will be described in this review: the structure and function of fibrillin-1; the fibrillin proteins; mutations in the FBN1 gene and pathogenic mechanisms; animal models. Finally, the currently available laboratory diagnostic tests and their limits will be discussed.
引用
收藏
页码:673 / 681
页数:9
相关论文
共 66 条
  • [1] QUANTITATIVE DIFFERENCES IN BIOSYNTHESIS AND EXTRACELLULAR DEPOSITION OF FIBRILLIN IN CULTURED FIBROBLASTS DISTINGUISH 5 GROUPS OF MARFAN-SYNDROME PATIENTS AND SUGGEST DISTINCT PATHOGENETIC MECHANISMS
    AOYAMA, T
    FRANCKE, U
    DIETZ, HC
    FURTHMAYR, H
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) : 130 - 137
  • [2] Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling
    Ashworth, JL
    Murphy, G
    Rock, MJ
    Sherratt, MJ
    Shapiro, SD
    Shuttleworth, CA
    Kielty, CM
    [J]. BIOCHEMICAL JOURNAL, 1999, 340 : 171 - 181
  • [3] The supramolecular organization of fibrillin-rich microfibrils
    Baldock, C
    Koster, AJ
    Ziese, U
    Rock, MJ
    Sherratt, MJ
    Kadler, KE
    Shuttleworth, CA
    Kielty, CM
    [J]. JOURNAL OF CELL BIOLOGY, 2001, 152 (05) : 1045 - 1056
  • [4] INTERNATIONAL NOSOLOGY OF HERITABLE DISORDERS OF CONNECTIVE-TISSUE, BERLIN, 1986
    BEIGHTON, P
    DEPAEPE, A
    DANKS, D
    FINIDORI, G
    GEDDEDAHL, T
    GOODMAN, R
    HALL, JG
    HOLLISTER, DW
    HORTON, W
    MCKUSICK, VA
    OPITZ, JM
    POPE, FM
    PYERITZ, RE
    RIMOIN, DL
    SILLENCE, D
    SPRANGER, JW
    THOMPSON, E
    TSIPOURAS, P
    VILJOEN, D
    WINSHIP, I
    YOUNG, I
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1988, 29 (03): : 581 - 594
  • [5] Béroud C, 2000, HUM MUTAT, V15, P86, DOI 10.1002/(SICI)1098-1004(200001)15:1<86::AID-HUMU16>3.0.CO
  • [6] 2-4
  • [7] AN ANIMAL-MODEL OF THE MARFAN-SYNDROME
    BESSER, TE
    POTTER, KA
    BRYAN, GM
    KNOWLEN, GG
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1990, 37 (01): : 159 - 165
  • [8] Revised genomic organization of FBN1 and significance for regulated gene expression
    Biery, NJ
    Eldadah, ZA
    Moore, CS
    Stetten, G
    Spencer, F
    Dietz, HC
    [J]. GENOMICS, 1999, 56 (01) : 70 - 77
  • [9] BOILEAU C, 1993, AM J HUM GENET, V53, P46
  • [10] NEONATAL MARFAN-SYNDROME WITH CONGENITAL ARACHNODACTYLY, FLEXION CONTRACTURES, AND SEVERE CARDIAC-VALVE INSUFFICIENCY
    BUNTINX, IM
    WILLEMS, PJ
    SPITAELS, SE
    VANREEMPST, PJ
    DEPAEPE, AM
    DUMON, JE
    [J]. JOURNAL OF MEDICAL GENETICS, 1991, 28 (04) : 267 - 273